Chlamydia is a bacterial infection caused by the organism Chlamydia trachomatis, and it spreads primarily through sexual contact, including vaginal, anal, and oral sex. It is the most commonly reported bacterial sexually transmitted infection in the United States and much of the developed world, yet most people who have it don’t know it because the infection frequently produces no symptoms at all. That silent quality is exactly what makes it worth understanding in some detail, because untreated chlamydia can cause serious reproductive damage in both women and men.
What Chlamydia Actually Is
Chlamydia trachomatis is an obligate intracellular bacterium, meaning it can only survive and reproduce inside human cells. It was first observed in 1907 by researchers who spotted it in conjunctival scrapings from an experimentally infected orangutan, though its role in genital infections took decades longer to pin down.1PubMed. Chlamydia trachomatis: milestones in clinical and microbiological diagnostics in the last hundred years: a review Unlike most bacteria, chlamydia cannot replicate on its own outside a host cell. It cycles between two forms: a tough, spore-like “elementary body” that can survive briefly outside cells and is the form that transmits between people, and a fragile “reticulate body” that divides rapidly once inside a cell. The elementary body has an unusually rigid outer membrane reinforced by cysteine-rich proteins, which helps it survive the trip from one person to another.2PubMed Central. Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp.
Because it depends entirely on living human cells, chlamydia dies quickly on surfaces, doorknobs, toilet seats, or shared towels. You cannot catch it from a swimming pool, a handshake, or sitting next to someone on a bus. This is not a pathogen that lingers in the environment the way some respiratory bacteria do.
How You Get It
The primary route is sexual contact. Any act that brings mucous membranes into contact with infected secretions can transmit the bacteria. That includes vaginal sex, anal sex, and oral sex. Condomless penile-anal sex is a particularly efficient route of transmission.3PubMed Central. The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission In vaginal sex, the bacteria typically infect the cervix in women and the urethra in men. In anal sex, the rectal lining becomes the site of infection. Oral sex can lead to throat infections, though these are less common and often clear on their own.
Transmission can also be more indirect than people realize. Mathematical modeling research has shown that sequential sexual practices within a single encounter can create unexpected transmission pathways. For example, if oral sex precedes anal sex, saliva carrying the bacteria from an infected throat to the penis could then transfer the infection to the rectum. Including these sequential-practice routes in models significantly improved the ability to explain why people are sometimes infected at multiple body sites simultaneously.4PubMed Central. Chlamydia trachomatis transmission between the oropharynx, urethra and anorectum in men who have sex with men: a mathematical model
The other major route is from mother to baby during vaginal delivery. In a five-year prospective study, about 5% of pregnant women had positive cervical cultures for chlamydia. Among their infants, roughly a third had the bacterium recovered from them after birth, and about 60% showed blood-test evidence of exposure. Eye infections developed in about 18% of exposed newborns, and chlamydial pneumonia in about 16%. Subclinical rectal and vaginal infections were also found in 14% of at-risk infants.5JAMA. Prospective Study of Perinatal Transmission of Chlamydia trachomatis This is why screening pregnant women matters, since treatment before delivery can prevent these infections in the newborn.
Why Most People Don’t Know They Have It
Chlamydia is sometimes called a “silent” infection because the majority of cases produce no noticeable symptoms. Estimates vary, but roughly three-quarters of infected women and about half of infected men experience no symptoms at all. When symptoms do appear, they tend to be mild and easy to dismiss: unusual discharge, burning during urination, or mild pelvic discomfort in women. Men might notice a watery discharge or slight testicular ache. These can be mistaken for a urinary tract infection or ignored entirely.
This asymptomatic nature is what makes chlamydia so effective at spreading. People who feel fine have no reason to seek testing unless they are screened routinely or a partner tells them about a positive result. By the time complications develop, the infection may have been present for months or even years.
Different Strains, Different Diseases
Not all chlamydia infections are alike. C. trachomatis comes in multiple strains, called serovars, and these are linked to distinctly different diseases. Serovars A through C cause trachoma, an eye infection that remains the world’s leading infectious cause of blindness, primarily in resource-poor settings. Serovars D through K are responsible for the common genital and eye infections seen in sexually active populations. And serovars L1 through L3 cause lymphogranuloma venereum, or LGV, a more invasive and aggressive condition.6Scientific Reports. Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014–2017 from Austrian patients
LGV deserves a separate mention because it behaves quite differently from typical genital chlamydia. It starts with a transient genital ulcer or bump, then progresses to painful, swollen lymph nodes in the groin, typically on one side. Left untreated, LGV can lead to abscesses, tissue strictures, and chronic pain.7Clinical Infectious Diseases. Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment In recent years, LGV outbreaks have been reported among men who have sex with men in Europe and North America, often presenting as rectal inflammation rather than the classical groin-node pattern.8PubMed Central. Lymphogranuloma venereum: diagnostic and treatment challenges
Who Is at Highest Risk
Age is the single strongest predictor. Younger sexually active adults, particularly those under 25, have substantially higher rates than older adults. A large U.S. analysis of national health survey data found that younger age was associated with more than three times the odds of testing positive compared to older adults.9Scientific Reports. Trends in chlamydia prevalence in the United States, 2005–2016 This isn’t simply a matter of more sexual partners, though that plays a role. The cervix in younger women is anatomically more susceptible to infection, and younger people are less likely to use barrier protection consistently.
Racial and ethnic disparities in chlamydia rates are stark and well-documented. The same U.S. study found that non-Hispanic Black individuals had roughly five times the odds of infection compared to their counterparts, and Mexican American individuals had about three times the odds.9Scientific Reports. Trends in chlamydia prevalence in the United States, 2005–2016 These disparities reflect access to healthcare, screening availability, socioeconomic factors, and patterns in sexual networks far more than they reflect individual behavior. Understanding this is important because it shapes where public health screening programs need to concentrate their efforts.
Complications in Women
Untreated chlamydia in women can ascend from the cervix into the uterus and fallopian tubes, triggering pelvic inflammatory disease, or PID. PID is the complication that causes the most lasting damage, because the inflammation can scar the fallopian tubes. A large retrospective cohort study found that women who tested positive for chlamydia had more than twice the risk of developing PID, nearly twice the risk of ectopic pregnancy, and a similarly elevated risk of infertility compared to women who tested negative.10Clinical Infectious Diseases. Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients
Chlamydia during pregnancy adds another layer of risk. A population-based prospective study found that chlamydial infection was associated with more than four times the odds of delivery before 32 weeks and about two and a half times the odds of delivery before 35 weeks.11PubMed Central. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study Preterm birth at those early gestational ages carries serious consequences for the infant, making this one of the stronger arguments for routine chlamydia screening in prenatal care.
Complications in Men
Men often get the impression that chlamydia is mainly a women’s health issue. It isn’t. Untreated infection in men can spread to the epididymis, the coiled tube behind each testicle, causing pain and swelling. In some cases it reaches the testicle itself or the prostate. A role for chlamydia in prostatitis has been reported in up to about 40% of patients in some studies.12Biology of Reproduction. Male Genital Tract Chlamydial Infection: Implications for Pathology and Infertility
Male fertility can also take a hit. Research shows that chlamydial infection can impair sperm quality across several measures: motility, concentration, morphology, DNA integrity, and the sperm’s ability to bind to an egg.13PubMed Central. HIV, HPV and Chlamydia trachomatis: impacts on male fertility One study found that men with chlamydia antibodies had lower counts of progressively moving sperm compared to antibody-negative men.14Fertility and Sterility. The role of Chlamydia trachomatis infection in male infertility The damage appears to involve both direct harm to sperm cells and the broader inflammatory response the body mounts against the infection.
Reactive Arthritis
One complication that surprises most people is that chlamydia can trigger joint inflammation. Reactive arthritis is an immune-mediated condition where, even after the infection itself has been treated, the body’s immune response continues to attack the joints. It typically affects the knees, ankles, and feet, and can also cause eye inflammation and urinary symptoms. A case report described a young man who developed recurrent reactive arthritis after a chlamydia infection that required progressively stronger immunosuppressive medications to control.15PubMed Central. When the Infection Clears but Inflammation Persists: A Case of Chlamydia-Associated Reactive Arthritis Requiring Disease-Modifying Antirheumatic Drug (DMARD) Therapy Reactive arthritis doesn’t happen to everyone with chlamydia, but it illustrates that the consequences of this infection extend well beyond the reproductive tract.
The underlying biology helps explain why. When the body detects chlamydia, the first response is local: immune cells rush to the site and release inflammatory signaling molecules, including interferon gamma. Those immune cells also produce reactive oxygen species and tissue-degrading enzymes like collagenase and elastase.16PubMed Central. The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword This inflammatory cascade is what clears the bacteria, but when the response overshoots or persists in the wrong tissues, it becomes the source of damage rather than defense.
How It’s Diagnosed
Testing for chlamydia is straightforward and doesn’t require a blood draw or invasive procedure. The standard method uses a nucleic acid amplification test, which detects the bacterium’s genetic material. For women, a vaginal swab is the most accurate option: a meta-analysis found it catches about 94% of infections, compared to about 87% for urine testing.17PubMed Central. Vaginal Swab vs Urine for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis: A Meta-Analysis The vaginal swab can be self-collected, which matters both for privacy and for access in non-clinical settings. For men, urine testing is the standard approach and works well.
Current U.S. guidelines recommend annual chlamydia screening for all sexually active women under 25 and for older women with risk factors such as new or multiple partners. The guidelines also recommend screening for pregnant women and for men who have sex with men. The rationale is simple: because most infections are asymptomatic, waiting for symptoms means missing most cases.
Treatment and the Shift Toward Doxycycline
Chlamydia is curable with antibiotics, but the preferred treatment has shifted in recent years. For a long time, a single dose of azithromycin was the go-to, prized for its convenience. However, head-to-head trials have shown that doxycycline, taken twice daily for seven days, is more reliably effective. In one trial, doxycycline had zero treatment failures, while azithromycin failed in about 3% of cases for urogenital infections.18PubMed Central. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection
The gap is even larger for rectal infections. A multicenter study found that doxycycline cured about 96% of rectal chlamydia infections in women, compared to roughly 79% for azithromycin, a difference of about 17 percentage points.19PubMed Central. Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure) For vaginal infections, both drugs performed similarly, with cure rates above 93%. But because rectal infections often go undetected and coexist with genital ones, doxycycline’s broader effectiveness has made it the current first-line recommendation in updated clinical guidelines.
The seven-day course of doxycycline does require more patient commitment than a single pill, and missed doses reduce its effectiveness. Partners also need to be treated simultaneously, or the infection simply bounces back and forth.
Getting Reinfected
Having chlamydia once does not protect you from getting it again. Reinfection is common, and guidelines recommend retesting roughly three months after treatment. In practice, retesting rates fall short of that target. One study across multiple clinical settings found that only about 44% of adolescent patients were retested within the recommended window, and among those who were, about 22% tested positive again.20PRiMER. Testing for Chlamydia Reinfection Among Adolescent Patients in Different Clinical Settings That reinfection rate of roughly one in five underscores how persistent the cycle can be, particularly when partners aren’t treated or when new exposures occur.
Each reinfection carries its own risk of complications. Repeated chlamydia infections compound the probability of tubal scarring, PID, and fertility problems. This is why partner notification and treatment are considered just as important as treating the index patient.
The Stigma Problem
One of the biggest barriers to testing isn’t logistical, it’s emotional. Research consistently shows that stigma discourages people from getting tested, disclosing results, and encouraging partners to seek care. A qualitative study found that both tested and untested young people anticipated shame and negative reactions if others found out about their testing. People tended to share their testing status only within a small, trusted circle. Because nobody disclosed more broadly, stigma was avoided in practice, but the anticipation of it was enough to keep many from testing in the first place.21PubMed Central. Chlamydia trachomatis testing among young people: what is the role of stigma?
The psychological impact of a positive result is real. In one study of people tested in general practice, about a third of infected individuals’ partners were upset about the result, and roughly 10% of relationships ended. Around 55 to 60% of both men and women who tested positive expressed anxiety about future infertility.22PubMed Central. Psychosocial impact of Chlamydia trachomatis testing in general practice A positive result did have one constructive effect: over 90% of infected women said they would use condoms more consistently in the future, though only about 56% of infected men said the same. These numbers suggest that a chlamydia diagnosis hits people harder emotionally than the medical gravity of a fully treatable infection would warrant, and that the emotional response doesn’t always translate equally into behavior change.
A systematic review of barriers to testing in primary care identified embarrassment, stigma, perceived low personal risk, and time constraints during clinic visits as the main obstacles, affecting patients and clinicians alike.23PubMed Central. Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review Self-collection kits for home use and online ordering of tests have emerged partly as responses to these barriers, removing the face-to-face interaction that many find most uncomfortable.
Chlamydia Beyond Humans
The bacterium that causes human genital infections, C. trachomatis, is only one member of a larger family. Related chlamydial species infect a remarkably wide range of animals, causing diseases of both veterinary and conservation importance.24PubMed. Chlamydia and Chlamydiales: more than meets the eye Chlamydia psittaci, for instance, is well known as a zoonotic pathogen: people who handle infected birds can develop psittacosis, a respiratory illness. Other species such as C. pecorum and C. pneumoniae have been found in wild animals including koalas, where chlamydial infections cause blindness, infertility, and population decline.25PubMed. Chlamydial infections in wildlife-conservation threats and/or reservoirs of ‘spill-over’ infections?
For the average person, the key practical point is that C. trachomatis is exclusively a human pathogen. You cannot catch genital chlamydia from your cat, your parrot, or any other animal. The chlamydial species that infect animals are distinct organisms with different host ranges. However, the broader chlamydia family is a useful reminder that this group of bacteria has been extraordinarily successful at exploiting the intracellular niche across the animal kingdom, and that the strategies C. trachomatis uses to hide inside human cells are ancient and deeply refined.